Cano Health Inc Revenue per Employee (CANO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cano Health Inc   (CANO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Cano Health Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Cano Health Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,094,546, below the company average number of $881,165.
Within the Healthcare sector Employees of 49 other companies have achieved higher revenue per employee. While Cano Health Inc 's total ranking has deteriorated compared to the previous quarter from 467 to 482. Cano Health Inc has 2,700 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CANO Revenue per Employee (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Revenue Change -21.05 % 5.27 % 18.5 % 11.22 % 23.08 %
Sales per Employee (TTM) $ 1,094,546 1,162,132 1,148,854 1,103,282 1,074,625
CANO's Total Ranking # 482 # 467 # 485 # 512 # 521
Seq. Revenue Change -4.41 % -9.14 % 2.78 % -11.55 % 27.45 %

CANO Company Profile >> Back to CANO Efficiency Comparisons >> Compare CANO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 8
Healthcare Sector # 50
Overall Market # 482

Revenue per Employee Statistics
High Average Low
$ 1,313,419 $ 881,165 $ 164,572
(Dec 31 2023)   (Jun 30 2021)



Financial Statements
Cano Health Inc 's Revenue MRQ $ 684 Millions Visit CANO's Income Statement
Cano Health Inc 's Revenues TTM $ 2,955 Millions Visit CANO's aggregate revenue growth
What are CANO's Sales? Visit CANO's Sales by Segment




Other Ratios
Cano Health Inc 's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CANO's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CANO's Competitors
Revenue per Employee for CANO's Suppliers
Revenue per Employee for CANO's Customers

You may also want to know
CANO's Sales Growth Rates CANO's Pe Price to earnings ratio CANO's Receivables Turnover Ratio CANO's Stock Quote
CANO's Net Income Growth Rates CANO's Ps Price to Sales ratio CANO's Sales per Employee CANO's Asset Turnover Ratio
CANO's Net Margin CANO's Pb Price to Book ratio CANO's Financial Strength Ratios CANO's Dividend Payout Ratio
Date modified: 2026-08-29T17:45:08+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2024Number of Employees Mar 31 2024
Hookipa Pharma inc   1,912,571.43 $ 53.552  Million 28 
United Therapeutics Corporation  1,784,500.00 $ 2,498.300  Million 1,400 
Cytomx Therapeutics Inc   1,727,217.39 $ 119.178  Million 69 
Sarepta Therapeutics Inc   1,680,598.80 $ 1,403.300  Million 835 
Gilead Sciences Inc   1,614,705.88 $ 27,450.000  Million 17,000 
Exelixis Inc   1,609,979.08 $ 1,846.646  Million 1,147 
Petros Pharmaceuticals inc   1,564,385.67 $ 4.693  Million 3 
Paragon 28 inc   1,553,048.61 $ 223.639  Million 144 
G1 Therapeutics Inc   1,528,018.18 $ 84.041  Million 55 
Prophase Labs Inc   1,500,157.89 $ 28.503  Million 19 
Aurinia Pharmaceuticals Inc   1,495,367.19 $ 191.407  Million 128 
Nektar Therapeutics  1,431,222.22 $ 90.167  Million 63 
Tvardi Therapeutics Inc   1,411,500.00 $ 16.938  Million 12 
Palvella Therapeutics Inc   1,411,275.86 $ 40.927  Million 29 
Keenova Therapeutics Plc  1,407,437.50 $ 2,251.900  Million 1,600 
Bristol myers Squibb Company  1,401,046.15 $ 45,534.000  Million 32,500 
Scilex Holding Company  1,383,676.47 $ 47.045  Million 34 
Journey Medical Corp  1,379,275.86 $ 79.998  Million 58 
Privia Health Group Inc   1,375,778.14 $ 1,686.704  Million 1,226 
Collegium Pharmaceutical Inc   1,336,496.45 $ 565.338  Million 423 
Prothena Corporation Public Limited Company  1,332,104.48 $ 89.251  Million 67 
Novavax inc   1,330,586.11 $ 996.609  Million 749 
Jazz Pharmaceuticals Plc  1,329,887.54 $ 3,843.375  Million 2,890 
Incyte Corporation  1,324,847.05 $ 3,767.865  Million 2,844 
Ispecimen inc   1,323,997.14 $ 9.268  Million 7 
Emergent Biosolutions Inc   1,316,222.22 $ 1,184.600  Million 900 
Progyny Inc   1,293,003.50 $ 1,106.811  Million 856 
Biogen Inc   1,288,413.33 $ 9,663.100  Million 7,500 
Fennec Pharmaceuticals Inc   1,284,342.86 $ 44.952  Million 35 
Puma Biotechnology Inc   1,266,078.21 $ 226.628  Million 179 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.